- €167.10m
- €981.63m
- €78.02m
- 15
- 46
- 14
- 14
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68 | 83.4 | 84.9 | 84.9 | 78 |
Cost of Revenue | |||||
Gross Profit | 37 | 61.9 | 63.3 | 63.7 | 49.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 23.4 | -10.9 | 56 | 38.1 | 104 |
Operating Profit | 44.6 | 94.3 | 28.9 | 46.9 | -25.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.1 | 80.8 | 16.1 | 36.9 | -4.18 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.1 | 80.8 | 16.1 | 36.9 | -4.18 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 33.1 | 80.8 | 16.1 | 36.9 | -4.18 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 33.2 | 80.6 | 16.1 | 36.9 | -4.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.25 | 4.91 | 0.98 | 2.21 | -0.246 |
Dividends per Share |